Human LY9 governs CD4 + T cell IFN-γ immunity to Mycobacterium tuberculosis
Science Immunology · 30.05.2025 · 10 (107)
DOI: 10.1126/sciimmunol.ads7377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 30.05.2025. Verfasst von Masato Ogishi und 52 weiteren Autor:innen. Beteiligte Einrichtung: St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA. Hauptthemen laut MEDLINE: Interferon-gamma, Mycobacterium tuberculosis, CD4-Positive T-Lymphocytes, Th1 Cells. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
CD4 + T cells are indispensable for optimal immunity to Mycobacterium tuberculosis ( M.tb ), a pathogen that triggers tuberculosis (TB) in humans. M.tb -specific human CD4 + T cells are known to polarize toward an interferon-γ (IFN-γ)–producing, CCR4 − CCR6 + CXCR3 + T-bet + RORγT + T helper 1* cell (T H 1*cell) memory phenotype. We report that autosomal recessive deficiency of the human lymphocytic surface receptor LY9 (SLAMF3 and CD229), which is found in less than 10 −5 individuals in the general population, underlies TB in three unrelated patients due to selective impairment in IFN-γ production by T H 1* cells. T H 1* cells express higher levels of LY9 than other CD4 + T cells. Mechanistically, LY9 polarizes naïve CD4 + T cells toward memory T H 1* cells by inducing T-bet via signaling lymphocytic activation molecule (SLAM)–associated protein (SAP) and RORγT (thymus-specific retinoid-related orphan receptor γ) without SAP. LY9 costimulation enhances TCR-driven IFN-γ production of memory T H 1*, but not T H 1, cells in a T cell–intrinsic manner via NFAT1 (nuclear factor of activated T cells 1) and RORγT. LY9 is likely to govern an optimal T H 1* cell– and IFN-γ–dependent protective immunity to M.tb in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
- David Rockefeller Graduate Program, Rockefeller University, New York, NY, USA.
- Institute of Microbiology, ETH Zürich, Zürich, Switzerland.
- Inborn Errors of Immunity Group, Department of Microbiology and Parasitology, School of Medicine, University of Antioquia (UdeA), Medellin, Colombia.
- School of Microbiology, University of Antioquia UdeA, Medellin, Colombia.
- Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
ORCID-Profile: Masato Ogishi, Julia Puchan, Rui Yang, Ji Eun Han, Tina Nguyen, Rebeca Gutiérrez-Cózar, Darawan Rinchai, Peng Zhang, Matthieu Chaldebas, Yi Feng, Anna-Lena Neehus, Ottavia M Delmonte, Taushif Khan, Daniel Eriksson, Jonathan Bohlen, Iris Fagniez, Simon J Pelham, Wei-Te Lei, Candice Laine, Ibtihal Benhsaien, Ahmed Abid, Ismail Abderrhamani Ghorfi, Hicham Souhi, D Sean Riminton, Olle Kämpe, Stuart E Turvey, Nico Marr, Luigi D Notarangelo, Nevin Hatipoglu, Aziz Bousfiha, Tayfun Ozcelik, Jamila El Baghdadi, Aurelie Cobat, Cindy S Ma, Laurent Abel, Anne Puel, Jacinta Bustamante, Pablo Engel, Philippe Gros, Stuart G Tangye, Federica Sallusto, Stéphanie Boisson-Dupuis, Jean-Laurent Casanova
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- Howard Hughes Medical Institute
Zitieren
APA
Ogishi, M., Puchan, J., Yang, R., Arias, A. A., Han, J. E., Nguyen, T., Gutiérrez-Cózar, R., Conil, C., Seeleuthner, Y., Rinchai, D., Zhang, P., Ponsin, K., Chaldebas, M., Feng, Y., Neehus, A. L., Delmonte, O. M., Khan, T., Landegren, N., Eriksson, D., …, & Casanova, J. L. (2025). Human LY9 governs CD4 + T cell IFN-γ immunity to Mycobacterium tuberculosis. Science Immunology, 10(107). https://doi.org/10.1126/sciimmunol.ads7377
Vancouver
Ogishi M, Puchan J, Yang R, Arias AA, Han JE, Nguyen T, et al. Human LY9 governs CD4 + T cell IFN-γ immunity to Mycobacterium tuberculosis. Science Immunology. 2025;10(107). doi:10.1126/sciimmunol.ads7377
BibTeX
@article{Ogishi2025,
author = {Ogishi, Masato and Puchan, Julia and Yang, Rui and Arias, Andrés Augusto and Han, Ji Eun and Nguyen, Tina and Gutiérrez-Cózar, Rebeca and Conil, Clément and Seeleuthner, Yoann and Rinchai, Darawan and Zhang, Peng and Ponsin, Khoren and Chaldebas, Matthieu and Feng, Yi and Neehus, Anna-Lena and Delmonte, Ottavia M and Khan, Taushif and Landegren, Nils and Eriksson, Daniel and Bohlen, Jonathan and Peel, Jessica N and Fagniez, Iris and Pelham, Simon J and Lei, Wei-Te and Chrabieh, Maya and Laine, Candice and Ouair, Hind and Benhsaien, Ibtihal and Abid, Ahmed and Abderrhamani Ghorfi, Ismail and Souhi, Hicham and Ouazzani, Hanane and Aniss, Rafik and Riminton, D Sean and Kämpe, Olle and Turvey, Stuart E and Marr, Nico and Notarangelo, Luigi D and Hatipoglu, Nevin and Bousfiha, Aziz and Ozcelik, Tayfun and El Baghdadi, Jamila and Cobat, Aurelie and Ma, Cindy S and Abel, Laurent and Puel, Anne and Bustamante, Jacinta and Engel, Pablo and Gros, Philippe and Tangye, Stuart G and Sallusto, Federica and Boisson-Dupuis, Stéphanie and Casanova, Jean-Laurent},
title = {Human LY9 governs CD4 + T cell IFN-γ immunity to Mycobacterium tuberculosis},
journal = {Science Immunology},
year = {2025},
volume = {10},
number = {107},
doi = {10.1126/sciimmunol.ads7377}
}
EUVIMED